Literature DB >> 3694384

Cyclotorsional diplopia following retinal detachment surgery.

H S Metz1, A Norris.   

Abstract

Four patients reporting symptoms of torsional diplopia following retinal detachment repair were seen. One patient most likely had a pre-existing, partially compensated superior oblique palsy as the cause of her vertical deviation and excyclotorsion. A second was found to have the superior oblique tendon adherent anteriorly to the encircling band and buckle just behind the superior rectus insertion, resulting in incyclotorsion. Release of these restrictions reduced the torsion to a small, asymptomatic degree. The third and fourth patients had excyclotorsion for unexplained reasons. Removing the scleral exoplant and Harada-Ito type surgery on the superior oblique tendon did not relieve the symptoms and only minimally reduced the excyclotorsion in one patient. A second procedure, with advancement of the anterior portion of the superior oblique tendon, successfully eliminated cyclotorsional symptoms.

Entities:  

Mesh:

Year:  1987        PMID: 3694384     DOI: 10.3928/0191-3913-19871101-05

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  4 in total

1.  Ocular torticollis.

Authors:  P R Mitchell
Journal:  Trans Am Ophthalmol Soc       Date:  1999

2.  Exotropia secondary to vitreous hemorrhage.

Authors:  T Fujikado; G Ohmi; T Ikeda; J M Lewis; Y Tano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-03       Impact factor: 3.117

3.  Risk factors influencing the outcome of strabismus surgery following retinal detachment surgery with scleral buckle.

Authors:  Ronen Rabinowitz; Federico G Velez; Stacy L Pineles
Journal:  J AAPOS       Date:  2013-11-09       Impact factor: 1.220

4.  Surgery for superior oblique tendon anteriorization and entrapment following scleral buckle.

Authors:  Melinda Y Chang; Fatma Yulek; Stacy L Pineles; Federico G Velez
Journal:  J AAPOS       Date:  2016-04       Impact factor: 1.220

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.